Tudor Investment Corp
RCUS icon

Tudor Investment Corp’s Arcus Biosciences RCUS Stock Holding History

Tudor Investment Corp’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.67M Buy
216,311
+7,672
+4% +$166K 0.01% 1211
2025
Q4 		$4.97M Buy
+208,639
New +$4.26M 0.01% 1155
2025
Q2 		– Sell
-53,466
Closed -$420K – 3672
2025
Q1 		$420K Buy
53,466
+10,498
+24% +$122K ﹤0.01% 2377
2024
Q4 		$640K Sell
42,968
-2,682
-6% -$43.8K ﹤0.01% 2046
2024
Q3 		$698K Buy
+45,650
New +$720K ﹤0.01% 1831
2023
Q4 		– Sell
-28,173
Closed -$506K – 2804
2023
Q3 		$506K Buy
+28,173
New +$566K 0.01% 1675
2021
Q4 		– Sell
-41,200
Closed -$1.44M – 2894
2021
Q3 		$1.44M Sell
41,200
-12,857
-24% -$400K 0.02% 929
2021
Q2 		$1.48M Buy
54,057
+46,796
+644% +$1.34M 0.03% 687
2021
Q1 		$204K Sell
7,261
-28,296
-80% -$985K ﹤0.01% 1427
2020
Q4 		$923K Buy
+35,557
New +$861K 0.03% 719
2020
Q3 		– Sell
-66,529
Closed -$1.65M – 1503
2020
Q2 		$1.65M Buy
+66,529
New +$1.8M 0.08% 307
2020
Q1 		– Sell
-13,423
Closed -$136K – 1272
2019
Q4 		$136K Buy
+13,423
New +$113K 0.01% 1038
2018
Q2 		– Sell
-27,723
Closed -$428K – 1199
2018
Q1 		$428K Buy
+27,723
New +$462K 0.01% 621

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Tudor Investment Corp's RCUS Position: Q1 2026 in Review

Tudor Investment Corp increased its Arcus Biosciences (RCUS) stake by 3.7% in Q1 2026, buying an estimated $166K and bringing the position to 216,311 shares worth $4.67M. The position accounts for 0.01% of the portfolio, ranked #1211.

Tudor Investment Corp first reported a position in RCUS in Q1 2018 and has held it in 13 quarters since. The position peaked at $4.97M in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Tudor Investment Corp held 216,311 shares of Arcus Biosciences worth $4.67M as of Q1 2026.
  • Tudor Investment Corp bought 7,672 Arcus Biosciences shares in Q1 2026, an estimated $166K.
  • Arcus Biosciences made up 0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #1211 holding.
  • Tudor Investment Corp first reported a position in Arcus Biosciences in Q1 2018 and has held it in 13 quarters since.
  • Tudor Investment Corp's Arcus Biosciences position peaked at $4.97M in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.